NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 35 filers reported holding NOVARTIS A G in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $275,862 | +8.3% | 2,708 | +7.3% | 0.30% | +13.7% |
| Q2 2023 | $254,621 | +9.7% | 2,523 | 0.0% | 0.26% | +6.1% |
| Q1 2023 | $232,139 | +1.4% | 2,523 | 0.0% | 0.25% | +3.8% |
| Q4 2022 | $228,909 | +6.0% | 2,523 | -1.2% | 0.24% | +10.7% |
| Q2 2022 | $216,000 | -11.8% | 2,553 | -8.6% | 0.22% | -0.5% |
| Q1 2022 | $245,000 | +0.4% | 2,793 | 0.0% | 0.22% | +10.2% |
| Q4 2021 | $244,000 | +7.0% | 2,793 | 0.0% | 0.20% | +6.5% |
| Q3 2021 | $228,000 | -10.6% | 2,793 | 0.0% | 0.18% | -10.7% |
| Q2 2021 | $255,000 | +6.7% | 2,793 | 0.0% | 0.21% | -1.0% |
| Q1 2021 | $239,000 | -9.5% | 2,793 | -0.1% | 0.21% | -15.8% |
| Q4 2020 | $264,000 | +2833.3% | 2,797 | +2697.0% | 0.25% | +1664.3% |
| Q3 2015 | $9,000 | -10.0% | 100 | 0.0% | 0.01% | +75.0% |
| Q2 2015 | $10,000 | 0.0% | 100 | 0.0% | 0.01% | 0.0% |
| Q1 2015 | $10,000 | +11.1% | 100 | 0.0% | 0.01% | +14.3% |
| Q4 2014 | $9,000 | – | 100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EXENCIAL WEALTH ADVISORS, LLC | 188,514 | $13,713,000 | 5.95% |
| PRENTISS SMITH & CO INC | 136,441 | $10,133,000 | 5.74% |
| MANAGED ASSET PORTFOLIOS, LLC | 204,985 | $15,225,000 | 5.46% |
| Osher Van de Voorde Investment Management | 108,725 | $8,075,000 | 4.40% |
| BROWN BROTHERS HARRIMAN & CO | 10,796,684 | $801,870,000 | 4.35% |
| SECTORAL ASSET MANAGEMENT INC | 472,296 | $35,077,000 | 4.10% |
| PROFESSIONAL ADVISORY SERVICES INC | 235,347 | $17,479,000 | 3.87% |
| Elefante Mark B | 5,619 | $417,000 | 3.78% |
| SPHERA FUNDS MANAGEMENT LTD. | 255,000 | $18,959,000 | 3.71% |
| CGOV Asset Management | 997,161 | $98,662,000 | 3.61% |